Skip to main content
RXRX logo

RXRX · Recursion Pharmaceuticals, Inc. · Share Buybacks

Track RXRX — free
$2.49 -0.23 (-8.46%) Play latest call Q2 2026 earnings call transcript
Market Cap
$1.53B
Shares
622.76M
Volume · Nov 20 29.66M Avg daily vol (3M) 24.44M

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Equity Offering (ATM) Programs

Program Established Capacity Remaining Runs Through
2026-02-25 $300,000,000 $300,000,000 as of 2026-06-30 —
2025-02 $500,000,000 $395,900,000 as of 2025-06-30 —
Key facts CIK 1601830 CUSIP 75629V104 13F (30d) 381 filings 327 filers Visit website Investor relations